Sveriges mest populära poddar
JAMA Clinical Reviews
Hälsa och motionMedicin

A Goal Too Far: Rethinking HbA1c Targets for Diabetes Treatment

29 min•19 juni 2018

The American College of Physicians just changed its guidance for how aggressively to treat type 2 diabetes, relaxing the HbA1c goal to something below 8 rather than 6.5 or 7 as other organizations recommend. This has stirred up substantial controversy. The rationale behind this decision is presented in this podcast.

Related article

Fler avsnitt av JAMA Clinical Reviews

Visa alla avsnitt av JAMA Clinical Reviews
Evaluating for Pediatric Concussion
•16 min
Iron Deficiency in Adults: Advances in Diagnosis and Treatment
•17 min
From the JAMA Network: Incidental Rotator Cuff Abnormalities on Magnetic Resonance Imaging
•15 min
Resistant Hypertension: Diagnosis and Management
•18 min
Update on Peanut Allergy
•19 min
Obesity-Related Cancer
•21 min
Diagnosis and Treatment of Chronic, Noninfectious Diarrhea
•20 min
Does This Patient Have Volume Overload? The Rational Clinical Examination
•19 min
Type 1 Diabetes: Diagnosis and Management
•17 min
Pharmaceutical Pricing: JAMA Talks With Mark Cuban
•33 min

JAMA Clinical Reviews med JAMA Network finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.